Observational study to assess the Ensure-based prediction of women with gestational diabetes mellitus who need insulin therapy

Observational study to assess the Ensure-based prediction of women with gestational diabetes mellitus who need insulin therapy - Study to assess the Ensure-based prediction of women with gestational diabetes mellitus who need insulin therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022665

Enrollment

100

Registered

2016-06-08

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

500 ml of oral Ensure Liquid (500 kcal)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women with gestational diabetes mellitus

Exclusion criteria

Exclusion criteria: The women who have diabetes before pregnancy; have overt diabetes during pregnancy; use the drug affecting blood glucose; have GAD65 antibody

Design outcomes

Primary

Measure	Time frame
Relation between values such as plasma glucose, insulin, and C peptide after Ensure-load and self-monitoring of blood glucose	—

Secondary

Measure	Time frame
To establish the cut-off point during Ensure-loading test which can detect women with gestational diabetes mellitus who need insulin therapy	—

Countries

Japan

Contacts

Public ContactTakuya Hashimoto

Hamamatsu University School of Medicine Second Division, Department of Internal Medicine

hamaihashimototakuya@yahoo.co.jp053-435-2263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026